Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Department of Radiation Oncology, Roshana Cancer Institute, Tehran, Iran.
Br J Radiol. 2019 Oct;92(1102):20190355. doi: 10.1259/bjr.20190355. Epub 2019 Jul 24.
The accuracy of dose delivery for intensity modulated radiotherapy (IMRT) treatments should be determined by an accurate quality assurance procedure. In this work, we used artificial neural networks (ANNs) as an application for the pre-treatment dose verification of IMRT fields based two-dimensional-fluence maps acquired by an electronic portal imaging device (EPID).
The ANN must be trained and validated before use for the pretreatment dose verification. Hence, 60 EPID fluence maps of the anteroposterior prostate and nasopharynx IMRT fields were used as an input for the ANN (feed forward type), and a dose map of those fluence maps that were acquired by two-dimensional Array Seven29 as an output for the ANN.
After the training and validation of the neural network, the analysis of 20 IMRT anteroposterior fields showed excellent agreement between the ANN output and the dose map predicted by the treatment planning system. The average overall global and local γ field pass rate was greater than 90% for the prostate and nasopharynx fields, with the 2 mm/3% criteria.
The results indicated that the ANN can be used as a fast and powerful tool for pretreatment dose verification, based on an EPID fluence map.
In this study, ANN is proposed for EPID based dose validation of IMRT fields. The proposed method has good accuracy and high speed in response to problems. Neural network show to be low price and precise method for IMRT fields verification.
调强放射治疗(IMRT)治疗的剂量传递准确性应通过准确的质量保证程序来确定。在这项工作中,我们使用人工神经网络(ANN)作为基于电子射野影像装置(EPID)获取的二维通量图的 IMRT 场的治疗前剂量验证的应用。
在用于治疗前剂量验证之前,ANN 必须经过训练和验证。因此,我们使用 60 个前后位前列腺和鼻咽癌调强放疗场的 EPID 通量图作为 ANN 的输入(前馈类型),并使用二维 Array Seven29 获得的那些通量图的剂量图作为 ANN 的输出。
在对神经网络进行训练和验证后,对 20 个 IMRT 前后场的分析表明,ANN 输出与治疗计划系统预测的剂量图之间具有极好的一致性。对于前列腺和鼻咽癌场,在 2 毫米/3%的标准下,全局和局部γ场的整体通过率平均大于 90%。
结果表明,ANN 可以作为基于 EPID 通量图的治疗前剂量验证的快速、强大工具。
在这项研究中,我们提出了一种基于 EPID 的 ANN 用于调强放射治疗场的剂量验证方法。所提出的方法在处理问题时具有良好的准确性和快速响应。神经网络在 IMRT 场的验证中显示出低价格和精确的方法。